Search

Emergency preparedness and response (EP&R) to radiological or nuclear accidents depends on many different stakeholder groups: nuclear and radiological regulators and authorities; institutions and ministries concerned by health, environment and consumption; first-line responders including the police, military, firefighters and health workers; as well as local authorities and nuclear industries. Stakeholders also include the general public, such as people living near NPPs8 or affected by previous nuclear or radiological accidents and incidents. Teachers and journalists, bloggers and other social media figures would play a key role in effective dissemination of knowledge and information. NGOs9 or civil associations/societies can also be involved in radiation monitoring and protection. The present study describes the role of different research institutions (such as CIEMAT10, UPM11 and ISGlobal12) and of the Spanish Society of Radiological Protection (SEPR) in bringing together the above-listed stakeholders in Spain to discuss EP&R and identify benefits and challenges of working together. Stakeholder opinions on EP&R, collected mainly in the framework of several European-funded projects, are provided. Remaining barriers and examples of good practices in radiation protection are discussed, as well as recommendations for improving nuclear and radiological emergency preparedness in Spain. The conclusions may be useful for other countries. [ABSTRACT FROM AUTHOR]

Proton therapy is an external radiotherapy using proton beams with energies between 70 and 230 MeV to treat some type of tumours with outstanding benefits, due to its energy transfer plot. There is a growing demand of facilities taking up small spaces and Compact Proton Therapy Centers (CPTC), with one or two treatment rooms, supposing the technical response of manufacturers to this request. A large amount of stray radiation is yielded in the interaction of proton beam used in therapy, neutrons mainly, hence, optimal design of shielding and verifications must be carried out in commissioning phases. Currently, almost 50 proton centers are under construction and start up in several countries, including ten in Spain. In the present work the effectiveness of shielding in two CPTC was verified with the Monte Carlo code MCNP6 by calculating the ambient dose equivalent, H*(10) due to secondary neutrons, outside the enclosures and walls of the center. The facilities modelled were the two centers currently operating in Spain, the first, since December 2019, with a superconductor synchrocyclotron, and the second, since March 2020, with a compact synchrotron. The geometry and materials are based on dimensions proposed a priori by the vendors, therefore, the paper is focused on check the suitability of the materials and thickness of the walls of the centers. Several models of the radiation sources were simulated, starting from a conservative assumptions, followed by more realistic scenarios. In all cases, the results reached for the ambient dose equivalent, H*(10), were below 1 mSv/year, which is the legal limit considered for the public in international references. Finally, considering that the recent ICRU Report 95 proposes changes in the operational quantities, the dose outside shieldingt has been evaluated in terms of the new next area surveillance quantity, H*, known as ambient dose, in the process of implementation. • Compact Proton Therapy Centers (CPTC) are a new trend in the development of proton facilities. • Benchmarking of ambient dose equivalent, H*(10), and ambient dose, H*, in CPTC, was carried out through MCNP6.2 code. • CPTC benchmarked were those with compact synchrocyclotrons and with compact synchrotrons operating in Spain in 2020. • Different scenarios and materials in barriers were considered in the assessment of shielding of CPTC. [ABSTRACT FROM AUTHOR]

Proton therapy (PT) is an external radiotherapy using proton beams with energies between 70 and 230 MeV to treat some type of tumours with outstanding benefits, due to its energy transfer plot. There is a growing demand of facilities taking up small spaces and Compact Proton Therapy Centers (CPTC), with one or two treatment rooms, supposing the technical response of manufacturers to this request. A large amount of stray radiation is produced in the interaction of protons used in therapy, neutrons mainly, hence, optimal design of shielding and verifications must be carried out in commissioning stages. Currently, almost 50 CPTC are under construction and start up in many countries, including several in Spain. In the present work, the effectiveness of shielding in a CPTC was verified with the Monte Carlo code MCNP6 by calculating the ambient dose equivalent, H*(10) due to secondary neutrons, outside the enclosures and walls of the center. The facility modelled was similar to one planned to start operating in 2019 in Spain, a CPTC, made up of a superconducting synchrocyclotron and one treatment room, with a configuration standard, shielding and width of barriers based on dimensions proposed a priori by the vendor. Therefore, the paper is focused in check the suitability of the materials and thickness of the walls of the center and develop the assessment of enclosures. Several models of the radiation sources and type of concrete in walls were simulated, starting from a conservative assumptions, followed by more realistic models. In all cases, the results were below 1 mSv/year, which is the international legal limit considered for the general public. This work is part of the project Contributions to Shielding and Dosimetry of Neutrons in Compact Proton Therapy Centers (CPTC). • Current proton therapy trends involve the building of Compact Proton Therapy Centers (CPTC). • The effectiveness of the shielding of a CPTC was carried out with the code MCNP6.2. • Even with the most conservative assumptions H*(10) is below 500 uSv/year. • Several scenarios were simulated as radiation sources, physical models or types of concrete. • The main sources of uncertainty were concrete density and composition and nuclear models. [ABSTRACT FROM AUTHOR]

Background: Nosocomial transmission of hepatitis C virus (HCV) in hemodialysis (HD) units is well established. In units with a high prevalence of HCV infection, the implementation of universal precautionary measures may not suffice in order to decrease the incidence and prevalence of HCV. In this setting strict isolation practices can be useful in order to achieve this goal. Methods: The incidence and prevalence of HCV infection amongst all HD and peritoneal dialysis (PD) patients from the province of Albacete, Spain, have been studied from 1992 to 2003.Through the 1993–1995 period chronic HD patients were treated either in a room exclusively for HCV– patients or in a room shared by HCV+ and HCV– patients. Complete separation of HCV+ and HCV– patients was implemented in 1995. Acute patients have been separated since 1992. The implementation of universal precautions was applied throughout the period. Results: There has not been a single seroconversion in the rooms where only HCV– patients were dialyzed during the 11 years of follow-up. There were two seroconversions in the rooms shared for 3 years by both HCV+ and HCV– patients. In 1995 the prevalence of HCV+ cases in HD and PD was 21.6 and 23.2%, respectively. Since then it has decreased steadily and in parallel for both therapies, and the current prevalence is 6.8% in HD and 5.7% in PD. Conclusions: In HD units with a high prevalence of HCV+ patients, strict isolation in combination with implementation of universal prevention measures can eliminate nosocomial transmission and obtain a long-term reduction in prevalence. Copyright © 2006 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]

In proton therapy facilities, high-energy neutron fields are generated as a consequence of (p,Xn) nuclear interactions. UPM has designed and tested its own extended-range Bonner Spheres Spectrometer (BSS) to support the development of this technology in Spain. This work shows the results obtained in the first experimental testing of this new BSS, using for the first time the ReBUNKI unfolding code in this kind of BSS. An intercomparison exercise with several unfolding codes has been carried out to validate ReBUNKI results and the new extended-range BSS response matrix. • Design and testing of a novel extended-range Bonner Spheres Spectrometer (BSS). • Comparison of neutron unfolding codes: BUNKIUT, NSDUAZ, NSDann, ReBUNKI and UMG. • Validation of ReBUNKI as a reliable unfolding code for extended-range BSSs. • Comparison of H*(10) estimations by different techniques: monitors and spectrometry. [ABSTRACT FROM AUTHOR]

Bartter syndrome (BS) is a heterogeneous group of autosomal recessive hypokalaemic salt-losing tubulopathies. Five types of BS caused by different genetic defects have been identified, and one of them is associated with sensorineural deafness (BSND). Mutations in the recently described BSND gene, mapped in chromosome 1p31, have been reported to be associated with BSND. This gene encodes barttin, an essential beta-subunit subunit for ClC-Ka and ClC-Kb channels. Both subunits are co-expressed in basolateral membranes of renal tubules, in the ascending limb of the loop of Henle, and in the stria vascularis of the inner ear. We studied two apparently unrelated Spanish families from the Canary Islands, with five members showing this pathology. Sequence analysis of the BSND gene showed that the affected members were homozygous for a C-to-T transition in exon 1, while their parents were heterozygous. This alteration results in a missense mutation, G47R, which has been previously shown to abolish the stimulatory effect on the subunit barttin of the ClC-Kb channel. Our results indicate that families with the G47R mutation indeed present polyhydramnios, premature birth and salt loss. Nevertheless, glomerular filtration rate was normal in all patients. Clinical manifestations are moderate in patients with the G47R mutation compared to other published data form patients with BSND. This constitutes the first report of BSND cases in Spain.